Xtant Medical Holdings IncXTNT
Price$0.36

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $109.5M-6.6% YoYTTM through 30 Jun 2026
Net Income -$11.1MTTM through 30 Jun 2026
Free Cash Flow -$696KTTM through 30 Jun 2026

Margins

Current
Gross Margin57.3%
EBITDA Margin-5.9%
Operating Margin-14.0%
Net Margin-10.2%

Returns

3.9%ROE
2.3%ROA

Balance Sheet Health

Debt / Equity0.26x
Current Ratio3.10x
Net Debt$0
Cash & Equivalents$9.9M

Quality Metrics

Altman Z-Score-2.48
Piotroski F-Score5 / 9
FCF Margin-0.6%
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $133.9M
Diluted EPS-$0.08TTM
'19'20'21'22'23'24'25
FY2025: $0.03

Dividend

No dividend

Capital Allocation

R&D Spend$2.2M
Capex Intensity1.2%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.